Jeddah, Saudi Arabia

Aisha Elaimi

This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2021.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aisha Elaimi: Innovator in Genetic Research

Introduction

Aisha Elaimi is a prominent inventor based in Jeddah, Saudi Arabia. She has made significant contributions to the field of genetic research, particularly in the area of in vitro fertilization (IVF). Her innovative work focuses on improving the detection of chromosomal abnormalities in human embryos.

Latest Patents

Aisha Elaimi holds a patent for a "Simplified PCR method for the detection of common aneuploidies in human reimplantation embryos." This patent provides methods for detecting aneuploidy in embryos created through in vitro fertilization. The technique utilizes a unique set of Short Tandem Repeat (STR) markers that can be rapidly and accurately quantified by multiplex PCR at the single-cell level. The markers include D13S284, D13S141, D18S54, D18S70, D21S266, D21S1951, and AMXY, which are essential for identifying abnormalities in chromosomes 13, 18, 21, and the XY chromosomes.

Career Highlights

Aisha Elaimi is affiliated with King Abdulaziz University, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential to enhance the success rates of IVF by enabling the selection of euploid embryos.

Collaborations

Aisha has collaborated with notable colleagues, including Adel Abuzinadah and Adeel Chaudhary, who have contributed to her research endeavors.

Conclusion

Aisha Elaimi's contributions to genetic research and her innovative patent demonstrate her commitment to advancing the field of reproductive medicine. Her work has the potential to significantly impact the future of in vitro fertilization and embryo selection.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…